Bafna Pharmaceuticals Limited (BAFNAPH) Share Price & AI Investment Analysis

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company offers its products in various dosage forms, including tablets, capsules, and solid orals. It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, and Nigeria. Bafna Pharmaceuticals Limited was founded in 1. Track Bafna Pharmaceuticals Limited's live NSE:BAFNAPH share price ₹343.20 (+1.99%), market cap ₹₹8B, P/E 104.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for BAFNAPH — real-time NSE India stock intelligence.